What is China Resources Pharmaceutical Group OCF Yield %?
China Resources Pharmaceutical GroupSTU:640 +2.97%63 OCF Yield % is 83.47 as of Jul. 04, 2026, which is 170% above its 10-year median of 30.92. GuruFocus rates STU:640 with a GF Score™ of 63/100 and a GF Value™ of €0.64 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,007 Drug Manufacturers companies, China Resources Pharmaceutical Group ranks better than 99.21% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
China Resources Pharmaceutical Group OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
China Resources Pharmaceutical Group OCF Yield % Related Terms
China Resources Pharmaceutical Group OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Pharmaceutical Group OCF Yield % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Pharmaceutical Group's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resources Pharmaceutical Group OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Resources Pharmaceutical Group's OCF Yield % distribution charts can be found below:
* The bar in red indicates where China Resources Pharmaceutical Group's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Pharmaceutical Group (STU:640) has a OCF Yield % of 83.47 as of Jul. 04, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on China Resources Pharmaceutical Group and its competitors. This is 170% above median its historical median of 30.92. Over the past decade, China Resources Pharmaceutical Group's OCF Yield % has ranged from 6.08 to 83.54. According to the industry distribution chart, China Resources Pharmaceutical Group ranks #8 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 0.8%.
Is China Resources Pharmaceutical Group's OCF Yield % too high?
China Resources Pharmaceutical Group's current OCF Yield % of 83.47 is 170% above median its 10-year median of 30.92. Over the past 10 years, this metric has ranged from a low of 6.08 to a high of 83.54. The Drug Manufacturers industry median OCF Yield % is 3.43. China Resources Pharmaceutical Group's value of 83.47 is 2333.5% above this industry median. Based on the distribution chart, China Resources Pharmaceutical Group ranks #8 out of 1007 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, China Resources Pharmaceutical Group has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China Resources Pharmaceutical Group's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, China Resources Pharmaceutical Group ranks #8 out of 1007 companies for OCF Yield %. This places China Resources Pharmaceutical Group in the top 1% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.43. China Resources Pharmaceutical Group's value of 83.47 is 2333.5% above this benchmark. Historically, China Resources Pharmaceutical Group's own OCF Yield % has ranged from 6.08 to 83.54 over the past decade. While the company's 10-year median is 30.92 vs. the industry median of 3.43, China Resources Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.43, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Resources Pharmaceutical Group's current OCF Yield % of 83.47 is 2333.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on China Resources Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Resources Pharmaceutical Group's current OCF Yield % is 83.47, which is 170% above median its own 10-year median of 30.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Pharmaceutical Group stock overvalued right now?
Based on GuruFocus' analysis, China Resources Pharmaceutical Group (STU:640) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.64, compared to a current price of €0.49 — trading 24.1% below its estimated fair value. The current OCF Yield % is 83.47, which is 170% above median its 10-year median of 30.92 and 2333.5% above the Drug Manufacturers industry median of 3.43. China Resources Pharmaceutical Group's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For China Resources Pharmaceutical Group (STU:640), the current OCF Yield % is 83.47 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Resources Pharmaceutical Group (STU:640) Overvalued in 2026?
Based on GuruFocus' analysis, China Resources Pharmaceutical Group stock appears to be undervalued.
The current stock price of €0.49 is trading 24.1% below its estimated GF Value™ of €0.64.
GuruFocus considers China Resources Pharmaceutical Group to be Modestly Undervalued.
Key valuation signals for STU:640:
OCF Yield %: 83.47 (170% above median its 10-year median of 30.92)
GF Value™: €0.64 vs. price of €0.49 (24.1% below fair value)
Industry Position: 2333.5% above the Drug Manufacturers median (#8 of 1007)
No single metric tells the full story. See the STU:640 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Resources Pharmaceutical Group Business Description
China Resources Pharmaceutical Group Ltd is principally engaged in the manufacture, distribution and retail of pharmaceutical and healthcare products. Specifically, the Group has four reportable segments as follows: Pharmaceutical manufacturing business, Pharmaceutical distribution business, Pharmaceutical retail business , and Other business operations. The company generates majority of its revenue from the Pharmaceutical distribution business.
63GF Score
Get the complete analysis for STU:640
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:640 has been successfully added to your 
